Kingsview Wealth Management, LLC

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1791965 GRANTS PASS, OR

Back to XERS Full portfolio

Position in XERS

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$79,200

+$21,200 QoQ

Shares Held

10,000

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#181

of 238 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Kingsview Wealth Management, LLC holds $4,805,592 across 3 Drug Manufacturers - Specialty & Generic names. XERS ranks #3 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	64,175	$4,611,615
2	HLN	Haleon plc	12,302	$114,777
3	XERS	Xeris Biopharma Holdings, Inc. This page	10,000	$79,200

All Filings in XERS

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$79,200	10,000	0.0%	Shares	Sole	2026-08-19
2026-03-31	$58,000	10,000	0.0%	Shares	Sole	2026-05-12
2025-12-31	$78,500	10,000	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.